Pay in 4 interest-free payments of $6.13 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
Beyond the obesity data, the Phase 3 study ACHIEVE-1 in people with early type 2 diabetes over 40 weeks documented an HbA1c change of -1.24, -1.47, and -1.48 percentage points at 3, 12, and 36 mg, versus -0.41 percentage points under placebo (Fras et al., NEJM 2025)
No meta-analysis with a sample size of children under the age of 12 comparable to this one has been conducted thus far
This unique dual-action approach helps with managing appetite suppression, digestion time, and insulin levels
[26], in a randomized controlled trial (RCT), analyzed the effects of LR-PRP and LP-PRP infiltration by comparing them with saline
Furthermore, weight loss was similar in participants who experienced GI side effects compared to those who did not, proving that the medications effectiveness operates independently of side effects through its direct metabolic and appetite-regulating mechanisms
